Radiation therapy causes side effects that range from mild fatigue and skin irritation during treatment to longer-lasting changes in the tissues and organs near the treatment site. The specific effects depend heavily on which part of the body is being treated, the total dose, and how many sessions are involved. Most short-term side effects improve within weeks to months after treatment ends, but some can develop months or years later.
Fatigue: The Most Common Side Effect
Fatigue affects more radiation patients than any other single side effect, regardless of where the treatment is aimed. It typically builds gradually over the course of treatment and can linger well after the final session. About one-third of patients still experience significant fatigue a full year after completing treatment, and for some, it can persist for up to five years or longer.
This isn’t ordinary tiredness. Radiation-related fatigue often doesn’t improve much with rest, and it can affect concentration, mood, and daily routines. It tends to be worse in patients receiving treatment to larger areas of the body or those undergoing chemotherapy at the same time. Light physical activity, structured sleep habits, and pacing daily tasks are the most consistently helpful strategies for managing it.
Skin Changes at the Treatment Site
The skin over the treated area almost always reacts to some degree. Early on, this looks and feels a lot like sunburn: redness, warmth, dryness, and sometimes peeling. In areas where skin folds against itself (under the breast, in the groin), the reaction can be more intense, with moist, raw patches that need careful wound care.
These changes usually peak toward the end of treatment and heal within a few weeks afterward. Over the long term, the treated skin may remain slightly darker, feel firmer, or become more sensitive to sun exposure. Gentle, fragrance-free moisturizers and loose clothing over the area help during the acute phase.
Head and Neck Radiation
Treatment directed at cancers in the head and neck region carries a distinct set of side effects because of the concentration of sensitive structures in a small area.
Dry mouth (xerostomia) is one of the most disruptive. The salivary glands are highly sensitive to radiation, and at doses around 35 Gy to the spared gland, saliva production drops to roughly 25% of its original flow within a year. Below about 50 Gy, there is typically some recovery of function between three months and one year after treatment. Above that threshold, the damage is more likely to be permanent. Chronic dry mouth increases the risk of cavities, gum disease, and difficulty swallowing, so dental care before and after treatment is a key part of the plan.
Mouth sores, throat pain, changes in taste, and difficulty swallowing are common during treatment and usually improve over the weeks that follow. Some patients develop thickened saliva or jaw stiffness that requires ongoing stretching exercises.
Cognitive Effects From Brain Radiation
When radiation targets the brain, cognitive changes can unfold in three phases. Acute effects, like headache and increased drowsiness, appear within days and are usually temporary. An early delayed phase develops within weeks to six months and can include attention problems, short-term memory lapses, and excessive sleepiness. This phase is also generally reversible.
The late delayed phase is the most concerning. It begins six months or more after treatment, tends to be progressive, and is often irreversible. The cognitive domains most affected are memory, executive function (planning, organizing, problem-solving), attention, and processing speed. These changes are especially pronounced when radiation reaches the frontal areas of the brain or the hippocampus, the structure most involved in forming new memories.
Chest and Lung Radiation
Radiation to the chest, commonly used for lung and breast cancers, can inflame the lungs and affect the heart. Radiation pneumonitis, an inflammatory reaction in lung tissue, typically develops one to six months after treatment. Symptoms include a dry cough, shortness of breath, and sometimes a low-grade fever. It can be difficult to distinguish from infection or disease progression, so diagnosis often requires imaging and ruling out other causes.
Heart effects are a longer-term concern, particularly for patients treated on the left side of the chest. Radiation can gradually stiffen blood vessels and heart valves, increasing the risk of coronary artery disease and other cardiac problems years down the line. Modern treatment planning works to minimize the dose reaching the heart, but the risk isn’t zero, especially at higher cumulative doses.
Pelvic Radiation
Radiation aimed at cancers in the pelvis (prostate, cervical, rectal, bladder) commonly affects the bowel and urinary tract.
Radiation proctitis, or inflammation of the rectum, can be acute or chronic. The acute form begins shortly after treatment starts and typically resolves within a few weeks of finishing. Symptoms include diarrhea, abdominal cramps, frequent urgent bowel movements, and blood or mucus in the stool. The chronic form can develop months to years later and may cause rectal bleeding, pain, and difficulty controlling bowel movements.
Bladder irritation follows a similar pattern: increased urinary frequency and urgency during treatment, with a small percentage of patients developing chronic symptoms afterward. Erectile dysfunction is a well-documented side effect for men treated for prostate cancer, occurring with both traditional photon-based therapy and newer proton beam approaches. Bowel and urinary problems also affect both treatment types. Clinical trials comparing the two are still working to determine whether proton therapy meaningfully reduces these side effects.
For women receiving pelvic radiation, vaginal dryness, narrowing, and discomfort during intercourse are common and can be long-lasting without proactive management using dilators and moisturizers.
Tissue Fibrosis and Lymphedema
One of the more persistent late effects of radiation is fibrosis: the gradual replacement of normal, flexible tissue with stiff scar-like tissue. This happens because radiation triggers a signaling process that promotes excessive collagen production in the treated area. Fibrosis can develop months to years after treatment and affects the skin, muscles, and internal organs within the radiation field. It can limit range of motion (particularly in the jaw, shoulder, or neck), cause tightness, and contribute to chronic discomfort.
Radiation also damages lymphatic vessels, the tiny channels that drain fluid from tissues. Even after visible swelling resolves, lymphatic function can remain impaired. This is why lymphedema, a chronic buildup of fluid that causes swelling in an arm or leg, can develop long after treatment ends, particularly in breast cancer patients who also had lymph nodes removed surgically. Early intervention with compression garments and specialized physical therapy offers the best outcomes.
Secondary Cancer Risk
Radiation, while treating one cancer, slightly raises the lifetime risk of developing a new, unrelated cancer in or near the treated area. An analysis of the entire U.S. cancer surveillance database from 1973 to 2014 found that at 20 years, the secondary cancer rate was 21.4% in patients who received radiation compared with 18.8% in those who did not. That translates to a relative risk increase of about 14%.
The absolute difference is modest, and it’s important to put it in context: the benefit of treating the existing cancer almost always outweighs this added risk. Secondary cancers typically take 10 to 20 years to appear, which is why long-term follow-up screening is part of survivorship care. Younger patients face a somewhat higher cumulative risk simply because they have more years ahead in which a secondary cancer could develop.
How Modern Techniques Reduce Side Effects
Radiation technology has advanced significantly over the past two decades. Techniques like intensity-modulated radiation therapy (IMRT) shape the radiation beam to match the tumor’s contour, delivering higher doses to the cancer while sparing more of the surrounding healthy tissue. This has made a measurable difference for organs like the salivary glands, where keeping the dose below critical thresholds can preserve function that would otherwise be permanently lost.
Proton therapy uses charged particles instead of traditional X-ray beams, and because protons deposit most of their energy at a specific depth, there is less “exit dose” passing through tissue beyond the tumor. In theory, this should reduce collateral damage. In practice, head-to-head comparisons are still limited. For prostate cancer, for example, ongoing clinical trials are actively testing whether proton therapy produces fewer bowel, urinary, and sexual side effects than IMRT. Both approaches carry the same categories of risk; the question is whether the severity and frequency differ enough to change treatment decisions.